View in EDS

Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.

Saved in:
Bibliographic Details
Title: Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.
Authors: Bisoendial R; Department of Immunology, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands; Department of Rheumatology and Clinical Immunology, Maasstad Hospital, 3079 DZ Rotterdam, the Netherlands; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Lipid Research Group, School of Biomedical Sciences, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address: bisoendialr@maasstadziekenhuis.nl., Kusienicka A; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria., Wielscher M; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria., Roediger B; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Novartis, 4056 Basel, Switzerland., Jain R; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria., Mitchell A; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia., Grau G; Vascular Immunology Unit, Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia., van Olden C; Department of Vascular Medicine, Academic Medical Center, 1105 AZ Amsterdam, the Netherlands., Stroes E; Department of Vascular Medicine, Academic Medical Center, 1105 AZ Amsterdam, the Netherlands., Tas S; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands., Van Eck M; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Gorlaeus Laboratories, 2333 AL Leiden, the Netherlands; Pharmacy Leiden, 2300 RA Leiden, the Netherlands., Youssef P; Rheumatology Department, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia., Cavanagh LL; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia., Rye KA; Lipid Research Group, School of Biomedical Sciences, University of New South Wales, Sydney, NSW 2052, Australia., Farlik M; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria., Weninger W; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria; Discipline of Dermatology, University of Sydney, Sydney, NSW 2006, Australia; Dermatology Department, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia. Electronic address: w.weninger@meduniwien.ac.at.
Source: Cell reports [Cell Rep] 2026 Mar 31; Vol. 45 (4), pp. 117212. Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41926284
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bisoendial+R%22">Bisoendial R</searchLink>; Department of Immunology, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands; Department of Rheumatology and Clinical Immunology, Maasstad Hospital, 3079 DZ Rotterdam, the Netherlands; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Lipid Research Group, School of Biomedical Sciences, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address: bisoendialr@maasstadziekenhuis.nl.<br /><searchLink fieldCode="AU" term="%22Kusienicka+A%22">Kusienicka A</searchLink>; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria.<br /><searchLink fieldCode="AU" term="%22Wielscher+M%22">Wielscher M</searchLink>; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria.<br /><searchLink fieldCode="AU" term="%22Roediger+B%22">Roediger B</searchLink>; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Novartis, 4056 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jain+R%22">Jain R</searchLink>; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria.<br /><searchLink fieldCode="AU" term="%22Mitchell+A%22">Mitchell A</searchLink>; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Grau+G%22">Grau G</searchLink>; Vascular Immunology Unit, Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22van+Olden+C%22">van Olden C</searchLink>; Department of Vascular Medicine, Academic Medical Center, 1105 AZ Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Stroes+E%22">Stroes E</searchLink>; Department of Vascular Medicine, Academic Medical Center, 1105 AZ Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Tas+S%22">Tas S</searchLink>; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Van+Eck+M%22">Van Eck M</searchLink>; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Gorlaeus Laboratories, 2333 AL Leiden, the Netherlands; Pharmacy Leiden, 2300 RA Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Youssef+P%22">Youssef P</searchLink>; Rheumatology Department, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Cavanagh+LL%22">Cavanagh LL</searchLink>; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Rye+KA%22">Rye KA</searchLink>; Lipid Research Group, School of Biomedical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.<br /><searchLink fieldCode="AU" term="%22Farlik+M%22">Farlik M</searchLink>; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria.<br /><searchLink fieldCode="AU" term="%22Weninger+W%22">Weninger W</searchLink>; Immune Imaging Program, The Centenary Institute of Cancer Medicine and Cell Biology, Sydney, NSW 2050, Australia; Department of Dermatology, Medical University of Vienna, Wien, Vienna 1090, Austria; Discipline of Dermatology, University of Sydney, Sydney, NSW 2006, Australia; Dermatology Department, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia. Electronic address: w.weninger@meduniwien.ac.at.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101573691%22">Cell reports</searchLink> [Cell Rep] 2026 Mar 31; Vol. 45 (4), pp. 117212. <i>Date of Electronic Publication: </i>2026 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101573691 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-1247 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41926284
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.celrep.2026.117212
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 117212
    Titles:
      – TitleFull: Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bisoendial R
      – PersonEntity:
          Name:
            NameFull: Kusienicka A
      – PersonEntity:
          Name:
            NameFull: Wielscher M
      – PersonEntity:
          Name:
            NameFull: Roediger B
      – PersonEntity:
          Name:
            NameFull: Jain R
      – PersonEntity:
          Name:
            NameFull: Mitchell A
      – PersonEntity:
          Name:
            NameFull: Grau G
      – PersonEntity:
          Name:
            NameFull: van Olden C
      – PersonEntity:
          Name:
            NameFull: Stroes E
      – PersonEntity:
          Name:
            NameFull: Tas S
      – PersonEntity:
          Name:
            NameFull: Van Eck M
      – PersonEntity:
          Name:
            NameFull: Youssef P
      – PersonEntity:
          Name:
            NameFull: Cavanagh LL
      – PersonEntity:
          Name:
            NameFull: Rye KA
      – PersonEntity:
          Name:
            NameFull: Farlik M
      – PersonEntity:
          Name:
            NameFull: Weninger W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2026 Mar 31
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2211-1247
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cell reports
              Type: main
ResultId 1